PJ, February 2000

Pharmaceutical public health: the end of pharmaceutical care?

The publication of "Better health, better Wales"1 in May 1998, and the emerging strategic framework2 along with their English3,4 and Scottish5 counterparts have set clear aims and priorities for improving all aspects of health and reducing health inequalities. This new remit is much broader than…

Parkinson’s disease: an overview

PD is the second most common neurodegenerative disease experienced by man, Alzheimer’s disease being the most common. It affects 1 per cent of the population over 65 years of age, rising to 2 per cent over 80 years. It is estimated that 5 per cent of patients are diagnosed before their 40th ye…

Over-the-counter ophthalmic preparations

We continue our series on eye disorders with an article discussing the use of over-the-counter products. OTC eye preparations can be used in the treatment of a number of common eye disorders, including conjunctivitis and dry eye conditions.…